lathosterol has been researched along with Coronary Artery Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakura, Y; Habara, M; Ishizuka, S; Ito, T; Katoh, O; Kimura, M; Kinoshita, Y; Ko, E; Kurita, T; Nasu, K; Suzuki, T; Terashima, M; Tsuchikane, E; Yokota, D | 1 |
| Chen, X; Gong, Z; Hao, Y; Li, Y; Liu, J; Qi, Y; Qin, L; Sun, J; Wang, M; Wang, W; Wang, Y; Xie, W; Zhang, Q; Zhao, D; Zhao, F | 1 |
| Fujimoto, K; Hokimoto, S; Ishihara, M; Kaikita, K; Koide, S; Komura, N; Matsui, K; Matsumura, T; Matsuyama, K; Morikami, Y; Nakamura, N; Nakamura, S; Nakao, K; Ogawa, H; Oka, H; Oshima, S; Sakaino, N; Sakamoto, K; Shimomura, H; Sugiyama, S; Sumida, H; Tsujita, K; Tsunoda, R; Yamamoto, N; Yamanaga, K; Yamashita, T | 1 |
| Boeing, H; Kuipers, F; Linseisen, J; Windler, E; Zyriax, BC | 1 |
| Boehm, BO; Fauler, G; Hoffmann, MM; Landl, EM; März, W; Renner, W; Silbernagel, G; Winkelmann, BR | 1 |
| Evans, RW; Orchard, TJ; Shay, CM | 1 |
| Endo, T; Fukui, K; Himeno, H; Iwahashi, N; Iwasawa, Y; Kimura, K; Kobayashi, S; Mochida, Y; Morita, Y; Okada, K; Sawada, R; Shigemasa, T; Shimizu, M; Shimizu, T; Uchino, K; Umemura, S; Wada, A | 1 |
| Gylling, H; Miettinen, TA | 1 |
| Brown, BG; Giovanni, A; Lichtenstein, AH; Matthan, NR; Schaefer, EJ | 1 |
| Angelin, B; Carlson, LA; Eriksson, M; Miettinen, TA | 1 |
3 trial(s) available for lathosterol and Coronary Artery Disease
| Article | Year |
|---|---|
Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.
Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ezetimibe; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Prospective Studies; Single-Blind Method; Treatment Outcome; Ultrasonography, Interventional | 2016 |
Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; Biomarkers; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Phytosterols; Proprotein Convertase 9; Proprotein Convertases; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Serine Endopeptidases; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL.
Topics: Antioxidants; Cholesterol; Constriction, Pathologic; Coronary Artery Disease; Desmosterol; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Niacin; Simvastatin; Sitosterols | 2003 |
7 other study(ies) available for lathosterol and Coronary Artery Disease
| Article | Year |
|---|---|
Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
Topics: Aged; Angina, Stable; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrosis; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Necrosis; Odds Ratio; Phytosterols; Plaque, Atherosclerotic; Predictive Value of Tests; Prognosis; Risk Factors; Rupture, Spontaneous; Tomography, Optical Coherence; Ultrasonography, Interventional | 2013 |
[Association between very low density lipoprotein cholesterol and cholesterol absorption/synthesis markers in patients with moderate and high risk of coronary heart disease].
Topics: Atorvastatin; Biomarkers; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Coronary Artery Disease; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phytosterols; Risk Factors | 2015 |
Association of plasma phytosterol concentrations with incident coronary heart disease Data from the CORA study, a case-control study of coronary artery disease in women.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cholesterol; Coronary Artery Disease; Female; Humans; Metabolic Syndrome; Middle Aged; Odds Ratio; Phytosterols; Risk Factors; Sitosterols | 2009 |
The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease.
Topics: Aged; Cholestanol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Phytosterols; Radiography; Sitosterols | 2009 |
Do plant sterol concentrations correlate with coronary artery disease in type 1 diabetes? A report from the Pittsburgh Epidemiology of Diabetes Complications Study.
Topics: Adult; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Desmosterol; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Phytosterols; Sitosterols | 2009 |
LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Topics: Aged; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Simvastatin; Sitosterols; Treatment Outcome | 2002 |
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Arteriosclerosis; Bile Acids and Salts; Biological Transport; Biomarkers; Cholesterol; Cholesterol, HDL; Coronary Artery Disease; Drug Evaluation; Feces; Heterozygote; Humans; Hyperlipoproteinemia Type II; Infusions, Intravenous; Liposomes; Liver; Male; Middle Aged; Phospholipids; Protein Precursors; Recombinant Fusion Proteins; Sterols | 1999 |